Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLOW: GLP-1 Plus Lifestyle for Overall Wellness
NCT06977438Phase 4Not yet recruiting
- Sponsor
- University of Minnesota
- Start
- Nov 2026
- Primary completion
- Jan 2031
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in obesity, sponsored by University of Minnesota. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06977438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06977438.